M. N. Tarasov

M. N. Tarasov

Auto-generated profile, based on publicly available information

M. N. Tarasov

Siberian State Medical University

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 January 2024 in Bulletin of Siberian Medicine
Verified
Journal Article
Open access
PDF file
SNS. S. Naumov
S. S. Naumov
NKNadezhda V. Krakhmal
Nadezhda V. Krakhmal
MTM. N. Tarasov
M. N. Tarasov
MTM. I. Taranenko
M. I. Taranenko
UEUdut Elena
Udut Elena
SVSergey V Vtorushin
Sergey V Vtorushin
Aim. To conduct a clinical and morphological assessment of the characteristics of colon cancer depending on the dMMR / pMMR status of the tumor.Materials and methods. A retrospective study included 66 patients with operable colorectal cancer (CRC) (T1-4bN0-2bM1), who were treated at Cancer Research Institute of Tomsk National Research Medical Center (NRMC). The average age of the patients was 64.4 ± 12.8 years. All patients underwent hemicolectomy or colon resection, as well as intraoperative resection of distant metastases, if present.Results. We determined that in CRC patients with pMMR tumors, hematogenous metastases were detected in 27.3% of cases, while in patients with dMMR tumors, hematogenous metastases were detected only in 6.1% of cases (p = 0.021). A comparative analysis of dMMR and pMMR tumors also allowed to establish higher frequency of perineural invasion among the pMMR subgroup of carcinomas (p = 0.039). The sign of tumor budding was found both in dMMR carcinomas (36%) and in pMMR tumors (45%). This sign was associated with damage to regional lymph nodes (p = 0.0017). A more detailed analysis of the tumor budding phenomenon showed that in dMMR tumors, Bd1 low-grade budding (83%) predominated. In pMMR tumors, Bd2 intermediate-grade budding (33%) and Bd3 high-grade budding (26.7%) prevailed. Bd2 and Bd3 tumor budding types were associated with hematogenous metastasis (p < 0.001).Conclusion. The obtained data demonstrate the differences in such pathomorphological parameters as perineural invasion and the degree of tumor budding depending on the dMMR / pMMR status of the tumor. These histologic parameters in tumor tissue are also associated with higher incidence of distant metastasis in patients with pMMR carcinomas as opposed to patients with dMMR tumors.

29 June 2022 in Siberian journal of oncology
Verified
Journal Article
Open access
PDF file
VTV. O. Tarakanova
V. O. Tarakanova
NKNadezhda V. Krakhmal
Nadezhda V. Krakhmal
SPS. V. Patalyak
S. V. Patalyak
MTM. N. Tarasov
M. N. Tarasov
NBNataliya Babyshkina
Nataliya Babyshkina
SVSergey V Vtorushin
Sergey V Vtorushin
The purpose of the study was to generalize information regarding the molecular and biological mechanisms involved in the resistance to endocrine therapy with aromatase inhibitors in patients with luminal breast cancer. Material and Methods. The literature search was conducted using Medline, Cochrane Library, Elibrary and PubMed databases. Results. The review highlights the results of international studies on molecular and biological characteristics of breast tumors and their relationship with the effectiveness of hormone therapy. Particular attention was paid to the description of modern studies on ROR1 and BMI-1 proteins and their contribution to the development of tumor resistance to treatment. Conclusion. The analysis of the world literature confrms the relevance of studying the molecular and genetic characteristics of tumor tissue in patients with luminal breast cancer. The data obtained were compared to the clinical course and response to hormone therapy in order to standardize them for implementation in everyday practice as the “gold standard of diagnosis”.

26 December 2025 in Bulletin of Siberian Medicine
Verified
Journal Article
Open access
PDF file
SVSergey V Vtorushin
Sergey V Vtorushin
MTM. N. Tarasov
M. N. Tarasov
APA. V. Pryazhenikova
A. V. Pryazhenikova
KVK. S. Vtorushin
K. S. Vtorushin
SNS. S. Naumov
S. S. Naumov
NKNadezhda V. Krakhmal
Nadezhda V. Krakhmal
This lecture presents current data on the role of regulatory proteins of epithelial-mesenchymal transition (EMT) in colorectal cancer (CRC) in the context of tumor molecular stratification and personalized treatment selection. EMT is a key biological process associated with tumor invasion, metastasis, chemoresistance, and immune evasion. Special attention is given to the characterization of CRC molecular subtypes according to the Consensus Molecular Subtypes (CMS) classification, particularly the CMS4 subtype with mesenchymal features, which is marked by high EMT activity and poor prognosis. The lecture discusses molecular and immunohistochemical markers indicative of EMT activation, including CDX2, ZEB1, HTR2B, FRMD6, BMI-1, and ROR1. The expression patterns and associated signaling pathways of these proteins are examined along with their influence on tumor aggressiveness, therapy resistance, and prospects for clinical application. Based on the literature analysis, the potential of these proteins as prognostic and possibly predictive biomarkers, as well as therapeutic targets, is discussed.